Frequently Asked Questions

Medibio is listed on the Australian Securities Exchange (ASX) under the ticker code of MEB. Medibio’s home exchange is Perth, Western Australia. Investors seeking to buy shares in Medibio should contact a licensed stockbroker.

Medibio’s share registry contact details are as follows:

Computershare Investor Services Pty Ltd
117 Victoria Street , West End, QLD, 4101
Phone (within Australia): 1300 850505
Fax: +61 (0)3 9473 2500

CHESS holders of Medibio shares should notify their sponsoring broker in writing of their new address details. Issuer sponsored holders should notify Computershare Investor Services Pty Ltd in writing at the address above, giving their full name, Security Reference Number and address details.

Contact your stockbroker for advice on how to consolidate multiple holdings in Medibio. If the names and addresses on more than one shareholding are the same and the holdings are issuer sponsored, the share registry can combine these holdings.

Medibio Limited is listed on the ASX under the ticker code of MEB. Refer to the ASX website (www.asx.com.au) for further information on Medibio shares.

Medibio’s auditors are as follows:

William Buck (Qld)
ABN 11 603 627 400
Level 21, 307 Queen Street Brisbane QLD 4000 Australia
GPO Box 563, Brisbane QLD 4001
Telephone: +61 7 3229 5100
Facsimile: +61 7 3221 6027

Medibio does not currently pay dividends. All of the Company’s funds are fully invested in commercialising its natural and sustainable product range, for the benefit of long-term growth in shareholder value.

Medibio does not currently have a DRP. Directors reserve the right to review the dividend policy, as appropriate.

Medibio has a 30 June balance date. The Company reports in February each year its half-year financial results for the six months to the end of December, while the full-year results are announced every August in accordance with ASIC and ASX requirements.

The Company also issues quarterly financial reports (Appendix 4C) in January, April, July and October. Final audited accounts are announced in September.
Medibio’s Annual Report is usually issued in October each year, prior to the Company’s Annual General Meeting in November.

Investors seeking more information on Medibio should refer to the Company’s ASX announcements. These announcements are also available via the ASX website (www.asx.com.au).

Investors with additional queries can contact the Company via our contact page.